Thursday, May 24, 2012 Last update: 10:04 AM
U.S. Technology Company News from the Inside
K-V Pharmaceutical Company
News articles for K-V Pharmaceutical Company:
Thursday, February 9, 2012
- K-V Pharmaceutical Announces Updated Makena® Performance Metrics and Investor Conference CallST. LOUIS, Feb. 9, 2012 /PRNewswire/ -- K-V Pharmaceutical Company (the "Company") (NYSE: KVa/KVb) today reported updated performance metrics for Makena®. Makena® was launched during March of 2011. From its launch date through January 31, 2012: -- Approximately 7,900 vials have been shipped to Ther-Rx customers ... read more
Wednesday, December 7, 2011
- K-V Pharmaceutical Company Comments on Recent Settlement With the Department of JusticeST. LOUIS, Dec. 7, 2011 /PRNewswire/ -- K-V Pharmaceutical Company (NYSE: KV.A/ KV.B) (the "Company" or "K-V"), today commented on the settlement of false claims allegations with the U.S. Department of Justice ("DOJ") associated with the Company's former ETHEX generic pharmaceutical subsidiary. In connection with a multi-defendant ... read more